{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:57:19Z","timestamp":1783785439308,"version":"3.55.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Use of valproate and certain other antiseizure medications (ASMs) in pregnancy is associated with abnormal fetal brain development with potential long-term implications for the child.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine whether use of valproate and other ASMs in pregnancy among mothers with epilepsy is associated with epilepsy risk in their children.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This prospective, population-based register cohort study included singletons born to mothers with epilepsy in Denmark, Finland, Iceland, Norway, and Sweden from January 1, 1996, to December 31, 2017. Data analysis was performed from October 2022 to December 2023.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Redeemed prescription for an ASM from 30 days before pregnancy until birth.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcome was epilepsy in children, assessed usingInternational Statistical Classification of Diseases and Related Health Problems, Tenth Revision<\/jats:italic>diagnoses from hospital care. Adjusted hazard ratios (AHRs) and 95% CIs were estimated using Cox proportional hazards regression. Secondary analyses included dose-response analyses, analyses using children of mothers who discontinued ASM prior to pregnancy as the reference, and sibling analyses.<\/jats:p><\/jats:sec>Results<\/jats:title>This cohort study included 38\u202f663 children of mothers with epilepsy (19\u202f854 [51.4%] boys). Children were followed up from birth; the mean length of follow-up was 7.2 years (range 0-22 years). Compared with 22\u202f207 children of mothers not using an ASM in pregnancy, increased risks of epilepsy in children of mothers who used valproate in pregnancy (monotherapy: AHR,\u20092.18; 95% CI, 1.70-2.79; polytherapy: AHR, 2.10; 95% CI, 1.49-2.96) were observed. However, there was no dose-dependent association, and there was a similar risk of epilepsy in siblings who were exposed and unexposed to valproate (AHR, 0.95; 95% CI, 0.50-1.82). Prenatal exposure to topiramate monotherapy was associated with increased risk of epilepsy (AHR, 2.32; 95% CI, 1.30-4.16), and the risk was greater for higher doses, but the risk attenuated in comparisons with children of mothers who discontinued topiramate before pregnancy (AHR, 1.19; 95% CI, 0.26-5.44). Prenatal exposure to clonazepam monotherapy was also associated with increased epilepsy risk (AHR, 1.90; 95% CI, 1.16-3.12), but limited follow-up and low numbers precluded further analyses. No associations were observed for prenatal exposure to lamotrigine (AHR, 1.18; 95% CI, 0.95-1.47), levetiracetam (AHR, 1.28; 95% CI, 0.77-2.14), carbamazepine (AHR, 1.13; 95% CI, 0.85-1.50), or oxcarbazepine (AHR, 0.68; 95% CI, 0.44-1.05).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study of children born to mothers with epilepsy, the associations found between prenatal exposure to certain ASMs and the child\u2019s risk of epilepsy did not persist in sensitivity analyses, suggesting that maternal ASM use in pregnancy may not increase epilepsy risk in children beyond that associated with the maternal epilepsy itself. These findings are reassuring for women in need of treatment with ASM in pregnancy.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.56425","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T16:32:33Z","timestamp":1708965153000},"page":"e2356425","source":"Crossref","is-referenced-by-count":13,"title":["Prenatal Exposure to Antiseizure Medications and Risk of Epilepsy in Children of Mothers With Epilepsy"],"prefix":"10.1001","volume":"7","author":[{"given":"Julie Werenberg","family":"Dreier","sequence":"first","affiliation":[{"name":"The National Centre for Register-Based Research, Aarhus University, Aarhus V, Denmark"},{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Christensen","sequence":"additional","affiliation":[{"name":"The National Centre for Register-Based Research, Aarhus University, Aarhus V, Denmark"},{"name":"Department of Neurology, Aarhus University Hospital, Affiliated Member of the European Reference Network EpiCARE, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannicke","family":"Igland","sequence":"additional","affiliation":[{"name":"Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway"},{"name":"Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[{"name":"Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland"},{"name":"Region Stockholm, Academic Primary Health Care Centre, Stockholm, Sweden"},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarit K.","family":"Leinonen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Affiliated Member of the European Reference Network EpiCARE, Aarhus, Denmark"},{"name":"Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kon Magne","family":"Vegrim","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Tomson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Zoega","sequence":"additional","affiliation":[{"name":"School of Population Health, Faculty of Medicine & Health, University of New South Wales Sydney, Sydney, Australia"},{"name":"Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjav\u00edk, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte-Helene","family":"Bj\u00f8rk","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Bromley","sequence":"additional","affiliation":[{"name":"Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Academic Health Science Centre, Manchester, United Kingdom"},{"name":"Royal Manchester Children\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"issue":"10282","key":"zoi231659r1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"zoi231659r3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","article-title":"Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei.","volume":"370","author":"Rodier","year":"1996","journal-title":"J Comp Neurol"},{"issue":"42","key":"zoi231659r4","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1523\/JNEUROSCI.0229-16.2016","article-title":"In utero exposure to valproic acid induces neocortical dysgenesis via dysregulation of neural progenitor cell proliferation\/differentiation.","volume":"36","author":"Fujimura","year":"2016","journal-title":"J Neurosci"},{"issue":"1","key":"zoi231659r5","doi-asserted-by":"crossref","first-page":"23471","DOI":"10.1038\/s41598-021-02994-6","article-title":"Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.","volume":"11","author":"Fereshetyan","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"zoi231659r6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1528-1167.2007.01056.x","article-title":"Fetal exposure to GABA-acting antiepileptic drugs generates hippocampal and cortical dysplasias.","volume":"48","author":"Manent","year":"2007","journal-title":"Epilepsia"},{"issue":"33","key":"zoi231659r7","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"zoi231659r8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/cercor\/bhm117","article-title":"Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid.","volume":"18","author":"Rinaldi","year":"2008","journal-title":"Cereb Cortex"},{"issue":"23","key":"zoi231659r9","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.222550499","article-title":"Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.","volume":"99","author":"Bittigau","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"zoi231659r10","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1528-1167.2010.02668.x","article-title":"Early cognitive development in children born to women with epilepsy: a prospective report.","volume":"51","author":"Bromley","year":"2010","journal-title":"Epilepsia"},{"issue":"11","key":"zoi231659r11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25570","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with intellectual disability and delayed childhood milestones.","volume":"3","author":"Daugaard","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi231659r12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"issue":"7","key":"zoi231659r13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability.","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"issue":"6","key":"zoi231659r14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jamaneurol.2023.0674","article-title":"Prenatal exposure to antiseizure medication and incidence of childhood- and adolescence-onset psychiatric disorders.","volume":"80","author":"Dreier","year":"2023","journal-title":"JAMA Neurol"},{"issue":"16","key":"zoi231659r15","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"zoi231659r16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yebeh.2018.12.031","article-title":"Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: the NEAD prospective observational study.","volume":"92","author":"Cohen","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"8","key":"zoi231659r17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","article-title":"Language skills of school-aged children prenatally exposed to antiepileptic drugs.","volume":"76","author":"Nadebaum","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"zoi231659r18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13023-019-1064-y","article-title":"Diagnosis and management of individuals with fetal valproate spectrum disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.","volume":"14","author":"Clayton-Smith","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"zoi231659r19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1471-4159.1988.tb02965.x","article-title":"Morphological and neurochemical effects of diazepam and phenobarbital on selective culture of neurons from fetal rat brain.","volume":"50","author":"Daval","year":"1988","journal-title":"J Neurochem"},{"issue":"13","key":"zoi231659r20","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/jnr.22125","article-title":"Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain.","volume":"87","author":"Chen","year":"2009","journal-title":"J Neurosci Res"},{"issue":"2","key":"zoi231659r21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/epi.13990","article-title":"Neonatal phenobarbital exposure disrupts GABAergic synaptic maturation in rat CA1 neurons.","volume":"59","author":"Al-Muhtasib","year":"2018","journal-title":"Epilepsia"},{"key":"zoi231659r22","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108533","article-title":"Neuropsychological effects in children exposed to anticonvulsant monotherapy during gestation: phenobarbital, carbamazepine, and phenytoin.","volume":"127","author":"Adams","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"7","key":"zoi231659r23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181042","article-title":"Association of prenatal exposure to benzodiazepines and child internalizing problems: a sibling-controlled cohort study.","volume":"12","author":"Brandlistuen","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"zoi231659r24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.braindev.2009.03.012","article-title":"Effects of antiepileptic drugs on mRNA levels of BDNF and NT-3 and cell neogenesis in the developing rat brain.","volume":"32","author":"Shi","year":"2010","journal-title":"Brain Dev"},{"issue":"2","key":"zoi231659r25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.expneurol.2004.01.025","article-title":"Therapeutic doses of topiramate are not toxic to the developing rat brain.","volume":"187","author":"Glier","year":"2004","journal-title":"Exp Neurol"},{"key":"zoi231659r26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2019.101729","article-title":"Prenatal exposure to oxcarbazepine increases hippocampal apoptosis in rat offspring.","volume":"103","author":"Gonz\u00e1lez-Maciel","year":"2020","journal-title":"J Chem Neuroanat"},{"key":"zoi231659r27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpsyt.2012.00019","article-title":"Epilepsy as a neurodevelopmental disorder.","volume":"3","author":"Bozzi","year":"2012","journal-title":"Front Psychiatry"},{"key":"zoi231659r28","doi-asserted-by":"crossref","first-page":"36250","DOI":"10.1038\/srep36250","article-title":"The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy.","volume":"6","author":"Choi","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"zoi231659r29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/acn3.51258","article-title":"Epilepsy risk in offspring of affected parents; a cohort study of the \u201cmaternal effect\u201d in epilepsy.","volume":"8","author":"Dreier","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"Pt 3","key":"zoi231659r30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/brain\/awt368","article-title":"Familial risk of epilepsy: a population-based study.","volume":"137","author":"Peljto","year":"2014","journal-title":"Brain"},{"issue":"3","key":"zoi231659r31","first-page":"257","article-title":"Higher risk of seizures in offspring of mothers than of fathers with epilepsy.","volume":"43","author":"Ottman","year":"1988","journal-title":"Am J Hum Genet"},{"issue":"9566","key":"zoi231659r32","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"zoi231659r34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01621459.2021.1906684","article-title":"To adjust or not to adjust? estimating the average treatment effect in randomized experiments with missing covariates.","author":"Zhao","year":"2022","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"zoi231659r35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.26561","article-title":"Comparative safety of antiseizure medication monotherapy for major malformations.","volume":"93","author":"Cohen","year":"2023","journal-title":"Ann Neurol"},{"issue":"1","key":"zoi231659r36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1975.tb04721.x","article-title":"The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967.","volume":"16","author":"Hauser","year":"1975","journal-title":"Epilepsia"},{"key":"zoi231659r37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2005.00354.x","article-title":"Genetic epidemiology of epilepsy or what do we tell families?","volume":"46","author":"Winawer","year":"2005","journal-title":"Epilepsia"},{"key":"zoi231659r38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2147\/CLEP.S285595","article-title":"Validation of pediatric idiopathic generalized epilepsy diagnoses from the Danish National Patient Register during 1994\u20132019.","volume":"14","author":"Boesen","year":"2022","journal-title":"Clin Epidemiol"},{"issue":"2-3","key":"zoi231659r39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.eplepsyres.2007.05.009","article-title":"Validation of epilepsy diagnoses in the Danish National Hospital Register.","volume":"75","author":"Christensen","year":"2007","journal-title":"Epilepsy Res"},{"issue":"5","key":"zoi231659r40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00001648-200109000-00006","article-title":"Do pregnant women report use of dispensed medications?","volume":"12","author":"Olesen","year":"2001","journal-title":"Epidemiology"},{"issue":"3","key":"zoi231659r41","first-page":"798","article-title":"Data Resource Profile: The Danish National Prescription Registry.","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"zoi231659r2","unstructured":"Medicines & Healthcare products Regulatory Agency. Research and analysis. Antiepileptic drugs: review of safety of use during pregnancy. January 7, 2021. Accessed December 12, 2023. https:\/\/www.gov.uk\/government\/publications\/public-assesment-report-of-antiepileptic-drugs-review-of-safety-of-use-during-pregnancy\/antiepileptic-drugs-review-of-safety-of-use-during-pregnancy"},{"key":"zoi231659r33","unstructured":"Bergen Epilepsy Research Group. SCAN-AED: Nordic register-based study of antiepileptic drugs in pregnancy. University of Bergen. April 28, 2023. Accessed December 12, 2023. https:\/\/www.uib.no\/en\/rg\/epilepsy\/123035\/nordic-register-based-study-antiepileptic-drugs-pregnancy-scan-aed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2815466\/dreier_2024_oi_231659_1708128504.13327.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T22:15:14Z","timestamp":1731449714000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2815466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.56425","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]}}}